🤖 Search 5,000+ AI tools Ask our bot for help →

Discover the latest tools and trends in AI 🔮

Join 50,000+ subscribers including Amazon, Apple, Google, and Microsoft employees reading our free newsletter.

[email protected] Subscribe

Qureight Secures $8.5M in Series A Funding

Qureight Secures $8.5M in Series A Funding
Qureight Secures $8.5M in Series A Funding

Qureight, a biotech company from Cambridge, UK, secured $8.5M in Series A funding.

The round was led by Hargreave Hale AIM VCT, with notable participation from XTX Ventures, Guinness Ventures, and others.

The funds will support Qureight's efforts in expanding operations and advancing R&D, particularly in clinical trial development through AI-powered data analysis.

Qureight, led by CEO Dr. Muhunthan Thillai, partners with major pharma firms like AstraZeneca and has signed R&D contracts with five NHS England trusts.

Comments